Intelligence Platform

Patents

Browse 47 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10221223

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease

The Regents of the University of California · Granted Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868725

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric m

Takeda Pharmaceutical Company Limited · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9724339

Methods and drug products for treating alzheimer's disease

Takeda Pharmaceutical Company Limited · Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9717710

Treatment of mild and moderate Alzheimer's disease

VTV THERAPEUTICS LLC · Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9585558

Hyperspectral imaging for early detection of Alzheimer'S Disease

Regents of the University of Minnesota · Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9517222

Method for the treatment of senile dementia of the Alzheimer's type

Phenomenome Discoveries Inc. · Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9512191

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease

The Regents of the University of California · Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9315534

Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9192644

Bioavailable curcuminoid formulations for treating Alzheimer's disease and other age-relat

The Regents of the University of California · Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9102666

Methods and drug products for treating Alzheimer's disease

Takeda Pharmaceutical Company Limited · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9102752

Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

United Biomedical, Inc. · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9034923

Methods for the treatment of senile dementia of the alzheimer's type

Phenomenome Discoveries Inc. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8951794

Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease

The Regents of the University of California · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8945858

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8617549

Bispecific nanobodies as a therapeutic for alzheimer's disease

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8394380

Compositions and methods for alzheimer's disease

Primex Clinical Laboratories, Inc. · Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8389478

Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease

The Regents of the University of California · Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8232373

Immunogenic peptide composition for the prevention and treatment of alzheimer's disease

United Biomedical, Inc. · Granted Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129334

Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease

The Regents of the University of California · Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7846892

Compositions and methods for Alzheimer's disease

Primex Clinical Laboratories, Inc. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479579

Triple transgenic mouse model of Alzheimer's disease

The Regents of the University of California · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6673332

Assays for inhibitors of neuronal transport of Alzheimer's amyloid precursor protein

The Regents of the University of California · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6410747

Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzhe

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired